Navigation Links
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Date:9/9/2008

butor relationships in those geographies.

"We are delighted to be partnering with Celling Technologies," said Dr. William Osgood, Chief Executive Officer of ThermoGenesis. "Their business model, which incorporates a high level of on-site service to clinicians, was a very important factor in our decision to establish our relationship," he added.

"We are excited about the significant market potential available to the ThermoGenesis product offering and the data we can collect through the research and development of stem cells utilizing their technology," noted Dr. Richard Suzuki, Director of Research & Development of Biomaterial Engineering for Celling Technologies. "The idea of automated controlled accuracy to provide consistent results to the patient and the market potential for cryopreservation of adult stem cells puts the technology of ThermoGenesis in a great position for leadership in an emerging industry."

ThermoGenesis received CE-Mark for the MXP, enabling the device to be marketed in the European Community and authorization from the FDA to begin marketing the MXP in the U.S., in June and July 2008, respectively.

Bone marrow derived stem cells are the dominant source of stem cells studied in regenerative medicine clinical trials for treating several large patient population diseases and injuries, including a number of orthopedic surgeries in the U.S. and international markets.

"We believe that clinicians will value the unique capability of the MXP to achieve significantly improved recovery of viable stem cells from bone marrow, as this is the greatest single success factor to a procedure," Osgood of ThermoGenesis commented.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery o
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. ThermoGenesis Names Tiffany Olson to Board of Directors
4. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
5. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
6. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
7. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Steel is emerging as one of the fastest growing green ... Green Energy Group and True Green Planet,s President and Recycling ... for over 25 years, stated that Spectrum Blue Steel is ... for spectacular earnings because of the bi products recovered by ...
(Date:12/2/2009)... 2 Reportlinker.com announces that a new ... catalogue: ,, Drug Discovery Technologies - ... Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, ... ongoing element of every pharmaceutical company,s business ...
(Date:12/2/2009)... Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... a dose confirmation and dosimetry trial of Cotara® in ... of brain cancer. Cotara is a targeted monoclonal ... potential new treatment for GBM. Cotara specifically targets ...
(Date:12/2/2009)... NV,the Netherlands based biotechnology company focusing on protein mimicking,technology ... it,has appointed Wim E.M. Mol, Ph.D. as new Chief ... will be responsible for all of Pepscans corporate functions ... He brings to,Pepscan more than 20 years of management ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2
... 20 Vical Incorporated,(Nasdaq: VICL ) today ... appointment of Andrew R. de Guttadauro as Vice ... de Guttadauro was Senior Director of,Strategy at Biogen ... the commercial development of that company,s Zevalin,the first ...
... Yang Mulia Pangkuan Negeri -, TORONTO, Aug. ... focused on developing simple blood-based biomarker tests for ... today,announced that its co-founder and Chief Scientific Officer, ... Pangkuan Negeri (DMPN), a State Honour,given by the ...
... Space, Poised for Market Launch, KIRKLAND, Wash., Aug. ... devices for the treatment of arterial,disease, today announced that ... and has started building its sales team in preparation ... System. Recently Pathway moved from its old 10,000-square-foot ...
Other Biology Technology:Vical Names Andrew de Guttadauro Vice President, Corporate Development 2Vical Names Andrew de Guttadauro Vice President, Corporate Development 3GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia 2Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2
(Date:12/3/2009)... a personality change in warmer water, according to an intriguing ... more aggressive. , Experiments with two species of young damselfish ... time that some reef fish are either consistently timid, or ... marked as water temperatures rise. , A slight lift of ...
(Date:12/3/2009)... world when it comes to investment in energy efficient ... (EPSRC) Chief Executive Dave Delpy believes that more is ... fuel cells, marine, wind and solar power solutions, but ... different solutions if we are to meet our carbon ...
(Date:12/2/2009)... PHILADELPHIA Less acculturated Latino men have a more ... acculturated to U.S. culture, but acculturation has no affect ... findings are published in Cancer Epidemiology, Biomarkers & ... Cancer Research. The December issue has a special focus ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Sarnova Names Hank Struik Chief Executive Officer 48162 1Sarnova Names Hank Struik Chief Executive Officer 48162 2Sarnova Names Hank Struik Chief Executive Officer 48162 3AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 1AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device 12520 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 1RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 2RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 3RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 4RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 5RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card 48161 6
... reveals that doctors treating life-threatening emergencies such as allergy attacks ... confusing labelling. , Adrenaline is stored in salt water in ... needed. The amount of adrenaline contained in the ampoule ... the drug per 1 mL of salt water) and a ...
... 28, 2007) -- For patients with hepatitis C, having ... associated with advanced disease. This problem is compounded by ... can further reduce platelet numbers to dangerously low levels, ... Now, research published in the New England Journal of ...
... Since the findings from the Human Genome Project and other ... been an enormous amount of research producing powerful evidence of ... explores some of the many relics of evolution found in ... OF EDEN: THE POWERFUL EVIDENCE OF EVOLUTION IN HUMAN DNA ...
Other Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 3There is powerful evidence of evolution in human DNA 2
Mouse Ameloblastin Biotinylated Affinity Purified PAb ENTREZ GeneID: 11698...
... to GRASP1 ( Abpromise for ... Antigen: Synthetic peptide corresponding to ... terminal region of rat GRASP1, conjugated ... Entrez GeneID: 56850 ...
Prepared from plasminogen by activation with immobilized human uPA...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Biology Products: